ArticleExperimental and therapeutic medicine2026
Crocin I delays cellular senescence potentially via modulating SIRT1/PKM2 expression to improve lactate homeostasis
Article in Experimental and therapeutic medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Crocin I has a protective effect against D-galactose-induced aging in rat models; however, its specific mechanism on delaying cellular senescence remains unclear. The aim of the present study was to investigate the interventional effect and related molecular mechanism of Crocin Ⅰ on replicative senescence and premature senescence of human embryonic lung diploid fibroblasts (WI-38) cells. Replicative senescence model was established through long-term culture and passaging to >55 PD. The premature senescence model was established using WI-38 cells treated with 2,2'-azobis-2-methy-propanimidamide dihydrochloride. The cell viability was detected by using a cell counting kit-8 assay, and the effects of Crocin Ⅰ on senescent phenotype of WI-38 cells were detected by senescence-associated β-galactosidase (SA-β-Gal) staining. In addition, the intracellular reactive oxygen species (ROS) level was detected by flow cytometry, and gene expression levels were detected by quantitative PCR. RNA sequencing analysis was performed to explore the alteration genes in senescent cells and the Crocin Ⅰ intervention group. The proteins PKM2, SIRT1, p53 and p21 in WI-38 cells were detected by western blotting, whereas cellular lactate level was detected by L-lactic acid content detection kit and pyruvate kinase (PK) enzyme activity was measured using PK activity assay kit. Crocin Ⅰ promoted cell proliferation within the range of 10-40 µM. In addition, Crocin Ⅰ decreased the SA-β-Gal staining positive rate on both replicative and premature senescent WI-38 cells. Furthermore, the intracellular ROS level was decreased by Crocin Ⅰ intervention. The differentially expressed genes were mainly enriched in phosphorylation, oxidation-reduction process, glucose metabolic process, cellular senescence pathway, glycolysis, hippo signaling pathway and pyruvate metabolism. RNA sequencing analysis and molecular docking revealed that PKM2 was one of the potential targets in Crocin Ⅰ against senescence activity. Furthermore, Crocin Ⅰ could enhance the expression of SIRT1 following with decreasing the level of PKM2, p21 and p53. Meanwhile, Crocin Ⅰ significantly decreased the cellular lactate level in WI-38. In conclusion, Crocin Ⅰ alleviated the replicative and premature senescence of WI-38 cells partially through regulating SIRT1 and PKM2 expression. Furthermore, this function may involve in glycolysis pathway.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.